Evidence map›Paper›PMID 40609540›Full record

ArticleMed (New York, N.Y.)2025

Conformational ligand-directed targeting of calcium-dependent receptors in acute trauma.

Renata Pasqualini, Christopher Markosian, Daniela I Staquicini, Andrey S Dobroff, Esteban Dodero-Rojas, Paul C Whitford, E Magda Barbu, Julianna K Bronk, Marina Cardó-Vila, Dawn R Christianson and 25 more

Abstract read
In one paragraph

Article in Med (New York, N.Y.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Renata PasqualiniRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: renata.pasqualini@rutgers.edu.
Christopher MarkosianRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA.
Daniela I StaquiciniRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA.
Andrey S DobroffDavid H. Koch Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Esteban Dodero-RojasCenter for Theoretical Biological Physics, Rice University, Houston, TX, USA.
Paul C WhitfordCenter for Theoretical Biological Physics, Northeastern University, Boston, MA, USA; Department of Physics, Northeastern University, Boston, MA, USA.
E Magda BarbuDavid H. Koch Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Julianna K BronkDepartment of Radiation Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Marina Cardó-VilaDepartment of Cellular & Molecular Medicine, University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA; Department of Otolaryngology and Head & Neck Surgery, University of Arizona Cancer Center, University of Arizona, Tucson, AZ, USA.
Dawn R ChristiansonDavid H. Koch Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Emmanuel Dias-NetoRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA; Laboratory of Medical Genomics, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Wouter H P DriessenDavid H. Koch Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Liliana Guzman-RojasCancer Research Program, Houston Methodist Research Institute, Houston, TX, USA.
Serena MarchiòDepartment of Oncology, University of Turin, Candiolo, TO, Italy.
Diana N NunesRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA; Laboratory of Medical Genomics, A.C. Camargo Cancer Center, São Paulo, SP, Brazil.
Francislon S de OliveiraDepartment of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil.
Michael G OzawaDepartment of Pathology, Stanford University School of Medicine, Stanford, CA, USA.
Bettina PronethInstitute of Metabolism and Cell Death, Helmholtz Center Munich, Neuherberg, BY, Germany.
Roberto RangelDepartment of Head & Neck Surgery, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Tracey L SmithRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA.
Glauco R SouzaDavid H. Koch Center, Houston, TX, USA; Department of Genitourinary Medical Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Fernanda I StaquiciniRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA.
Fenny H F TangRutgers Cancer Institute, Newark, NJ, USA; Division of Cancer Biology, Department of Radiation Oncology, Rutgers New Jersey Medical School, Newark, NJ, USA.
Wallace B BazeKeeling Center for Comparative Medicine & Research, Department of Comparative Medicine, University of Texas MD Anderson Cancer Center, Bastrop, TX, USA.
João C SetubalDepartment of Biochemistry, Institute of Chemistry, University of São Paulo, São Paulo, SP, Brazil.
John W BurnsUS Army Institute of Surgical Research, Fort Sam Houston, TX, USA.
Michael A DubickUS Army Institute of Surgical Research, Fort Sam Houston, TX, USA.
Juri G GelovaniOffice of the Provost, United Arab Emirates University, Al Ain, Abu Dhabi, UAE; Department of Radiology, College of Medicine & Health Sciences, United Arab Emirates University, Al Ain, Abu Dhabi, UAE; Department of Radiology, Siriraj Hospital, Mahidol University, Bangkok, Thailand; Department of Biomedical Engineering, College of Engineering and School of Medicine, Wayne State University, Detroit, MI, USA.
Andriy I BatchinskyAutonomous Reanimation & Evacuation (AREVA) Research Institute and Innovation Center, The Geneva Foundation, San Antonio, TX, USA.
Jon E MogfordDefense Sciences Office, Defense Advanced Research Projects Agency, Arlington, VA, USA.
Charles E WadeCenter for Translational Injury Research, Department of Surgery, McGovern Medical School at the University of Texas Health Science Center, Houston, TX, USA; CAG Center for Endotheliomics, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.
John B HolcombCenter for Injury Science, University of Alabama at Birmingham, Birmingham, AL, USA; Division of Acute Care Surgery, Department of Surgery, University of Alabama at Birmingham, Birmingham, AL, USA.
Stephen K BurleyRCSB Protein Data Bank, Rutgers, The State University of New Jersey, Piscataway, NJ, USA; RCSB Protein Data Bank, San Diego Supercomputer Center, University of California, San Diego, La Jolla, CA, USA; Institute for Quantitative Biomedicine, Rutgers, The State University of New Jersey, Piscataway, NJ, USA; Rutgers Cancer Institute, New Brunswick, NJ, USA.
José N OnuchicCenter for Theoretical Biological Physics, Rice University, Houston, TX, USA; Department of Biosciences, Rice University, Houston, TX, USA; Department of Chemistry, Rice University, Houston, TX, USA; Department of Physics & Astronomy, Rice University, Houston, TX, USA.
Wadih ArapRutgers Cancer Institute, Newark, NJ, USA; Division of Hematology/Oncology, Department of Medicine, Rutgers New Jersey Medical School, Newark, NJ, USA. Electronic address: wadih.arap@rutgers.edu.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI DIANE BODURKA · 1985 to 2026
$290.8M
TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
NCI NIH HHS P30 CA016672NCI NIH HHS P30 CA072720
6 · The paper itself

Abstract

backgroundTrauma is a leading cause of mortality, but injury-specific molecular targets remain largely unknown. We hypothesized that distinctive yet unrecognized tissue targets accessible to circulating ligands might emerge during trauma, thereby underscoring a trauma-related proteome.

methodsWe screened a peptide library to discover targets in a porcine model of major trauma: compound femur fracture with hemorrhagic shock. Bioinformatics yielded conserved motifs, and candidate receptors were affinity purified. In silico and in vitro approaches served to investigate possible associations between candidate receptors and calcium, a major component of skeletal muscle and bone. In vivo homing and molecular imaging (PET/MRI and SPECT/CT) studies of the most promising ligand peptide candidate were performed in the porcine model and were also confirmed in a corresponding rat model of major trauma. Optical methodologies and molecular dynamics simulations served to explore the molecular attributes of the ligand-receptor binding.

findingsNearly all molecular targets of the selected ligand peptides were calcium-dependent proteins, which become accessible upon trauma. We validated specific binding of homing peptides to these receptors in injured tissues, including CLRGFPALVC:CASQ1, CSEIGVRAC:HSP27, and CRQRPASGC:CALR. Notably, we determined that ligand peptide CRQRPASGC targets an injury-specific calcium-facilitated conformation of calreticulin, enabling specific molecular imaging of trauma.

conclusionsWe conceptually propose the term "traumome" for the functional receptor repertoire that becomes readily amenable for ligand-directed targeting upon major trauma. These preclinical findings pave the way toward clinic-ready targeted theragnostic approaches in the setting of trauma.

fundingMajor funding was provided by the Defense Advanced Research Projects Agency (DARPA).

Indexed as

CalciumFemoral FracturesShock, HemorrhagicAnimalsDisease Models, AnimalLigandsMalePeptide LibraryRatsSwineCalciumLigandsPeptide Libraryacute traumacalciumcalreticulincompound fracturein vivo screeningpeptide libraryphage displayPre-clinical researchreceptorshocktrauma-related proteome

Identifiers

PMID40609540
PMCPMC12955825

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.